[Epidemiology of viral hepatitis A to E in Germany].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz

Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.

Published: February 2022

AI Article Synopsis

  • Viral hepatitis A to E consists of different infections caused by specific hepatitis viruses (A to E), which affect the liver and have diverse characteristics in terms of how they spread and how they can be treated.* -
  • In Germany, there are legal requirements for reporting cases of viral hepatitis, ensuring that data about infections and related health issues are shared with health authorities like the Robert Koch Institute.* -
  • The article discusses the current epidemiology and challenges in managing hepatitis, emphasizing the need for better vaccination, improved access to prevention and treatment options, and enhanced food safety measures to prevent outbreaks.*

Article Abstract

Viral hepatitis A to E describes various infectious inflammations of the liver parenchyma that are caused by the hepatitis viruses A to E (HAV, HBV, HCV, HDV, and HEV). Although the clinical pictures are similar, the pathogens belong to different virus families and differ in terms of pathogenesis, transmission routes, clinical course, prevention, and therapy options. In Germany, there is mandatory reporting according to the Infection Protection Act (IfSG) for direct or indirect laboratory evidence and for suspicion, illness, and death of viral hepatitis. The data are transmitted to the Robert Koch Institute.In this article, on the basis of published studies and notification data, we describe the epidemiology of hepatitis A to E as well as current challenges and prevention approaches. In particular, the latter contains the improvement of existing vaccination recommendations (hepatitis A and B); improvement of access to prevention, testing, and care including therapy with antiviral drugs (hepatitis B, C, and D) and the detection and prevention of foodborne infections and outbreaks; and improvements in the field of food safety (hepatitis A and E).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758919PMC
http://dx.doi.org/10.1007/s00103-021-03478-8DOI Listing

Publication Analysis

Top Keywords

hepatitis a to e
12
viral hepatitis a
8
hepatitis a
5
[epidemiology viral
4
to e
4
to e germany]
4
germany] viral
4
to e describes
4
describes infectious
4
infectious inflammations
4

Similar Publications

Identification of enzymes responsible for extracellular alginate depolymerization and alginate metabolism in Vibrio algivorus.

Appl Microbiol Biotechnol

February 2017

Process Development Laboratories, Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-8681, Japan.

Alginate is a marine non-food-competing polysaccharide that has potential applications in biorefinery. Owing to its large size (molecular weight >300,000 Da), alginate cannot pass through the bacterial cell membrane. Therefore, bacteria that utilize alginate are presumed to have an enzyme that degrades extracellular alginate.

View Article and Find Full Text PDF

Unlabelled: We compared the renal metabolism of 9 alpha-fluorinated steroids with that of the unfluorinated, endogenous steroid cortisol (F). By defining kinetic variables, we characterized isoenzyme activities of 11 beta-hydroxysteroid-dehydrogenase (11 beta-HSD).

Methods: I) In human kidney slices, we studied the conversion of 9 alpha-fluoro-cortisol (FF) and F to their oxo-products (and vice versa).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!